A measured look at Dihexa, why almost all of the evidence is in animals, and what a careful self-experimenter would actually log.
What Cerebrolysin is, why the stroke evidence is genuinely mixed, and the metrics worth logging if you use it.
A spadin analog that targets TREK-1. What the mechanism implies, why it is research-only, and what to log.
What P21 is, why the human evidence is essentially zero, and how to track it honestly if you choose to experiment at all.
A practical look at proprietary blends like KLOW, and why tracking them honestly means accepting you cannot isolate any one ingredient.
What B7-33 is, why it is studied in fibrosis and cardiac research, and why human tracking is currently very limited.